0001415889-23-004626.txt : 20230309 0001415889-23-004626.hdr.sgml : 20230309 20230309211807 ACCESSION NUMBER: 0001415889-23-004626 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230308 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Englese Thomas CENTRAL INDEX KEY: 0001825799 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39577 FILM NUMBER: 23721436 MAIL ADDRESS: STREET 1: C/O AZIYO BIOLOGICS, INC. STREET 2: 12510 PROSPERITY DRIVE, SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 FORMER NAME: FORMER CONFORMED NAME: Englese Tom DATE OF NAME CHANGE: 20200923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AZIYO BIOLOGICS, INC. CENTRAL INDEX KEY: 0001708527 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474790334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 BUSINESS PHONE: 240-247-1143 MAIL ADDRESS: STREET 1: 12510 PROSPERITY DRIVE STREET 2: SUITE 370 CITY: SILVER SPRING STATE: MD ZIP: 20904 4 1 form4-03102023_020301.xml X0306 4 2023-03-08 0001708527 AZIYO BIOLOGICS, INC. AZYO 0001825799 Englese Thomas C/O AZIYO BIOLOGICS, INC. 12510 PROSPERITY DRIVE, SUITE 370 SILVER SPRING MD 20904 false true false false CHIEF COMMERCIAL OFFICER Class A Common Stock 2023-03-08 4 M 0 937 0 A 18206 D Class A Common Stock 2023-03-09 4 S 0 289 4.30 D 17917 D Restricted Stock Units 2023-03-08 4 M 0 937 0 D Class A Common Stock 937 1875 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs"). Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022. /s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese 2023-03-09